PHGE (BiomX Ltd) קצב צמיחת רווח למניה בשנה הנוכחית

BiomX Inc. (PHGE) creates unique viral cocktails to combat resistant bacteria, serving as a replacement for antibiotics. The year-over-year volatility in earnings per share illustrates the dynamics of these processes, where the 0.00 mark records this indicator. BiomX Inc. (PHGE) seeks global expansion through B2B partnerships in the field of phage therapy. The business relies on internal testing cycles, maintaining resilience against macroeconomic fluctuations.

This indicator captures the annual growth rate of net earnings per share as a percentage. The calculation is based on a comparison of the current EPS value against the same period last year. By analyzing the annual change in earnings per share, an investor assesses the business scaling rates. For BiomX Inc. (PHGE), this metric reflects the costs of bacteriophage development. The absence of revenue makes this indicator dependent on the success of clinical trials.